Revolution Medicines RVMD Income Statement (2019-2026)

NASDAQ RVMD
$208.57 -2.30 (-1.09%)
As of: Sep 4, 2026 · 11:50 AM EDT
Reported Financials

Revolution Medicines Quarterly Income Statement

Periods 30 quarters
Latest Jun 2026

Revolution Medicines reported net income of -$644.37M for the quarter ended Jun 2026. This income statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
73.65M74.14M74.23M74.46M87.82M90.41M106.30M109.14M109.45M113.15M164.91M165.65M167.75M185.90M186.26M186.90M189.71M197.00M200.18M214.24M
Revenue & cost
Revenue
1.10M9.46M7.58M9.12M3.36M15.33M7.01M3.82M0.74M
Operating items
Amortization - Intangibles
0.30M
Research & DevelopmentR&D
46.47M53.68M56.49M61.00M69.45M66.13M68.95M97.98M107.73M148.48M118.02M134.93M151.75M188.10M205.75M224.13M262.51M294.94M343.97M394.92M
Wages, Salaries and OtherWages
25.16M26.33M27.39M35.17M37.19M41.17M46.88M63.82M61.53M78.63M
Selling, General & AdministrativeSG&A
7.79M8.69M9.04M10.20M10.43M10.91M13.22M14.64M15.51M32.24M22.84M21.71M23.96M28.21M35.01M40.58M52.76M66.68M101.25M110.21M
Operating ExpensesOpex
54.26M62.37M65.53M71.20M79.89M77.04M82.17M112.62M123.25M180.72M140.86M156.64M175.71M216.31M240.76M264.71M315.27M361.63M445.22M505.13M
Operating IncomeOp. Inc
-53.16M-52.91M-57.95M-62.09M-76.53M-61.71M-75.16M-108.80M-123.25M-179.98M-140.86M-156.64M-175.71M-216.31M-240.76M-264.71M-315.27M-361.63M-445.22M-505.13M
EBIT
-53.16M-52.91M-57.95M-62.09M-76.53M-61.71M-75.16M-108.80M-123.25M-179.98M-140.86M-156.64M-175.71M-216.31M-240.76M-264.71M-315.27M-361.63M-445.22M-505.13M
Non-operating items
Non Operating Interest Expenses
2.81M-2.81M0.87M11.43M11.94M12.20M23.78M
Interest & Investment IncomeInt & Inv Inc
0.22M0.24M-0.91M-0.48M2.91M-1.75M1.22M-0.69M10.95M18.98M-1.74M-0.67M20.41M21.23M0.39M22.40M22.08M21.29M-3.85M35.58M
Other Non Operating IncomeOther Non Op Inc.
-2.81M0.02M0.28M-0.01M-0.03M58.15M0.12M-0.01M
Non Operating IncomeNon Op. Inc.
0.22M0.24M0.30M0.87M2.91M5.08M7.06M10.50M10.95M18.79M24.86M23.41M19.42M20.99M27.34M16.93M10.06M-3.27M-8.59M-139.24M
Net income details
EBT
-52.94M-52.68M-57.65M-61.22M-73.63M-56.63M-68.10M-98.30M-112.30M-161.99M-116.00M-133.23M-156.29M-195.32M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Tax ProvisionsTaxes
-0.30M-0.12M-3.87M0.34M-0.80M
Profit After TaxPAT
-52.94M-53.17M-57.65M-61.22M-73.33M-57.91M-68.10M-98.30M-108.43M-161.54M-116.00M-133.23M-156.29M-194.57M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Income from Continuing OperationsIncome (Continuing)
-52.94M-52.68M-57.65M-61.22M-73.33M-56.51M-68.10M-98.30M-108.43M-162.33M-116.00M-133.23M-156.29M-194.52M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Consolidated Net IncomeConsol Net Inc.
-52.94M-52.68M-57.65M-61.22M-73.33M-56.51M-68.10M-98.30M-108.43M-162.33M-116.00M-133.23M-156.29M-194.52M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Income towards Parent CompanyParent Net Inc
-52.94M-52.68M-57.65M-61.22M-73.33M-56.51M-68.10M-98.30M-108.43M-162.33M-116.00M-133.23M-156.29M-194.52M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-52.94M-52.68M-57.65M-61.22M-73.33M-56.51M-68.10M-98.30M-108.43M-161.54M-116.00M-133.23M-156.29M-194.57M-213.42M-247.79M-305.21M-364.89M-453.82M-644.37M
Additional items
EPS (Basic)
-0.72-0.72-0.78-0.82-0.87-0.70-0.72-0.92-0.99-1.43-0.70-0.81-0.94-1.16-1.13-1.31-1.61-1.92-2.29-3.06
EPS (Diluted)
-0.72-0.72-0.78-0.82-0.87-0.70-0.72-0.92-0.99-1.43-0.70-0.81-0.94-1.16-1.13-1.31-1.61-1.92-2.29-3.06
Shares Outstanding
73.54M72.81M74.16M74.28M84.69M80.63M94.83M106.88M109.23M113.15M164.73M165.14M166.84M167.74M188.15M188.58M189.23M190.13M198.10M210.89M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
73.54M72.81M74.16M74.28M84.69M80.63M94.83M106.88M109.23M113.15M164.73M165.14M166.84M167.74M188.15M188.58M189.23M190.13M198.10M210.89M
EBITDA
-53.16M-52.91M-57.95M-62.09M-76.53M-61.71M-75.16M-108.80M-123.25M-179.98M-140.86M-156.64M-175.71M-216.31M-240.76M-264.71M-315.27M-361.63M-445.22M-505.13M
Interest ExpensesInt Expense
2.81M-2.81M0.87M11.43M11.94M12.20M23.78M
Tax Rate
0.400.223.44-0.210.41